SCHEMBL844873

SCHEMBL844873

CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.63
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
SCN9A Q15858 2/20 0.54
SCN3A Q9NY46 1/20 0.54
SCN5A Q14524 1/20 0.54
LMNA P02545 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
JAK2 O60674 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
ALDH1A1 P00352 2/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
POLB P06746 1/20 0.44
USP30 Q70CQ3 1/20 0.44
DPP4 P27487 2/20 0.43
DPP8 Q6V1X1 1/20 0.43
PABPC1 P11940 1/20 0.43
PTPN2 P17706 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10299164 0.90 NPC1 (0.76) NPC1MEN1KMT2ALMNANPSR1
SCHEMBL845227 0.90 NPC1 (0.76) NPC1MEN1KMT2ALMNANPSR1
SCHEMBL10281278 0.90 NPC1 (0.76) NPC1MEN1KMT2ALMNANPSR1
SCHEMBL10119593 0.90 NPC1 (0.51) NPC1MEN1KMT2ASCN9ASCN3A
SCHEMBL872886 0.88 KDM4E (0.52) NPC1MEN1KMT2ALMNANPSR1
SCHEMBL10119639 0.84 MEN1 (0.46) NPC1MEN1KMT2ASCN9ASCN3A
SCHEMBL10119687 0.83 CYP2C9 (0.44) NPC1ALDH1A1MAPK1HTTHDAC8
SCHEMBL3736620 0.81 NPC1 (0.54) NPC1MEN1KMT2ASCN9ASCN3A
SCHEMBL628425 0.81 NPC1 (0.54) NPC1MEN1KMT2ASCN9ASCN3A
SCHEMBL3736622 0.81 NPC1 (0.54) NPC1MEN1KMT2ASCN9ASCN3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed